2026 NSGC Webinar Series Full Package
-
Register
- Non-member - $475
- Member - $400
This all-inclusive package offers access to the full set of 24 webinars from NSGC’s 2026 Webinar Series, complete with CEUs. Please note that webinars will be added to this package as they are released.
To purchase the 2026 NSGC Webinar Series Full Package, click the blue "Register Now" button next to the package title. Do not register for the individual components included in the package.
Genetic Counselor CEUs:
The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to 2.4 CEUs or 24 Category 1 contact hours for the 2026 NSGC Webinar Series Full Package. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.
Content expires December 31, 2027.
Member Price: $400
Non-member Price: $475
-
Contains 4 Component(s), Includes Contact Hours
In this webinar, we will assess the upcoming implementation of genomes sequencing as the first-tier prenatal diagnostic test for all patients and consider the implications for non-invasive exome/genome sequencing. We will additionally consider the value of community and data sharing to drive this field forward.
Genome sequencing (GS) has emerged as a promising alternative to existing prenatal diagnostic methods. GS offers a single, high-resolution approach capable of simultaneously detecting a broad spectrum of genetic alterations below the detection threshold of CMA, impacting medical management in pregnancy, delivery, and neonatal care. In this webinar, we will assess the upcoming implementation of genomes sequencing as the first-tier prenatal diagnostic test for all patients and consider the implications for non-invasive exome/genome sequencing. We will additionally consider the value of community and data sharing to drive this field forward.
Presented by:
NSGC Prenatal SIG
Jessica L. Giordano, MS, CGCLearning Objectives:
1. Examine the value of genome sequencing in prenatal diagnosis as a single-tier, comprehensive test for all patients
2. Assess benefits and limitations of different sequencing consenting and reporting strategies
3. Explore the future state of non-invasive exome/genome sequencing
4. Discuss the value of community and data sharing to move the field of prenatal diagnosis forwardGenetic Counselor CEUs:
The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, The future is here: Genome Sequencing as the first line prenatal diagnostic testing. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.
Successful Completion:
1. View recording
2. Pass quiz
3. Complete evaluationContent expires December 31, 2027.
Member Price: $35
Non-member Price: $50 -
Contains 4 Component(s), Includes Contact Hours
Presented by the NSGC Metabolism & Lysosomal Storage Diseases SIG.
This session will explore emerging prenatal therapies for lysosomal storage disorders, including in utero enzyme replacement and gene therapy. Attendees will learn about the PEARL Trial, the first clinical study of prenatal enzyme replacement therapy, along with early safety and outcome data. The session will also examine future applications of fetal gene therapy and the evolving role of genetic counselors in early diagnosis, patient counseling, care coordination, and access to prenatal precision medicine.
Presented By:
NSGC Metabolism & Lysosomal Storage Diseases SIG
1. Billie Lianoglou, ScM, CGCLearning Objectives:
1. Describe the clinical rationale and emerging evidence supporting prenatal intervention for severe monogenic disorders, with a focus on in utero enzyme replacement therapy for lysosomal storage diseases.
2. Review the design, implementation, and interim outcomes of the PEARL Trial, including patient selection, procedural considerations, and early safety and efficacy findings.
3. Recognize benefits and limits related to prenatal administration of AAV9 gene insertion for GM1 gangliosidosis including data from the pediatric experience and rationale for moving the intervention to the prenatal period.
4. Discuss the role of the UCSF Center for Genome Surgery in integrating genomic diagnosis, therapeutic development, and clinical translation to expand access to precision therapies for patients with rare genetic diseases.
5. Highlight emerging opportunities and challenges for genetic counselors as prenatal genomic therapies move from reseGenetic Counselor CEUs:
The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, Fetal Therapy for Monogenic Disorders - PEARL Trial: In Utero Enzyme Replacement Therapy for Lysosomal Storage Diseaseses. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.
Successful Completion:
1. View recording
2. Pass quiz
3. Complete evaluationContent expires December 31, 2027.
Member Price: $35
Non-member Price: $50 -
Contains 4 Component(s), Includes Contact Hours
Join us to explore how AI can be applied responsibly throughout the case review process. Discover which tasks can be automated, where human expertise delivers the greatest value, and how to achieve the right balance between efficiency and scientific oversight.
As next-generation sequencing (NGS) becomes the standard of care, a laboratory's competitive advantage is no longer defined by the test itself, but by how effectively it leverages data, automation, and innovation. Laboratories that embrace AI, invest in scalable data infrastructure, and integrate intelligent workflows are better positioned to increase efficiency, expand testing capacity, and contribute to learning health systems.
Join us to explore how AI can be applied responsibly throughout the case review process. Discover which tasks can be automated, where human expertise delivers the greatest value, and how to achieve the right balance between efficiency and scientific oversight.
Presented by:
NSGC Genomic Technologies SIG
1. Talia Silver, MHScLearning Objectives:
1. Explain the technical layer of genomics lab operations.
2. Explain different forms of AI, where and how they can be used, and what guardrails can enable safe adoption in a lab setting.
3. Explain how automation, and utilization of software stand to improve lab operations.
4. Explain how structured data storage enables reanalysis and research and what it can enable for healthcare systems.Genetic Counselor CEUs:
The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, Software and AI: How Responsible Use Enables Analysis and Variant Curation at Scale. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.
Successful Completion:
1. View recording
2. Pass quiz
3. Complete evaluationContent expires December 31, 2027.
Member Price: $35
Non-member Price: $50 -
Contains 4 Component(s), Includes Contact Hours
This session pulls back the curtain on modern genetic testing laboratories, mapping out the lifecycle of a sample from initial accessioning to complex variant classification and reporting.
This session pulls back the curtain on modern genetic testing laboratories, mapping out the lifecycle of a sample from initial accessioning to complex variant classification and reporting. Panelists will demystify the operational, regulatory, and business constraints that shape lab policies, explaining the root causes behind turnaround times and reporting limitations. By addressing the perspective gap between clinic and laboratory, attendees will learn practical strategies to troubleshoot common delays and collaborate effectively with lab genetic counselors for better patient care.
Presented by:
NSGC Lab/Industry SIG
1. Matt Tschirgi, MS, CGC
2. Elizabeth Kramer Dugan, MGC, CGC
3. Elysia Pagano, MGC, CGCLearning Objectives:
1. Evaluate the operational, business, and cross-functional drivers behind genetic testing laboratory decisions, business metrics, and turnaround times.
2. Trace the journey of a sample through accessioning, triage, automation, and reporting.
3. Identify factors that impact testing capacity and workflow limitations.
4. Analyze the root causes of discrepancy between clinical expectations and lab capabilities, including requisition requirements, variant classification constraints, and reporting policies.
5. Apply practical communication strategies and best practices—such as providing detailed phenotype data and engaging effectively with lab genetic counselors—to streamline case management and optimize patient outcomes.Genetic Counselor CEUs:
The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, Things I Wish I Knew in Clinic: The Realities of Lab Operations and Industry. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.
Successful Completion:
1. View recording
2. Pass quiz
3. Complete evaluationContent expires December 31, 2027.
Member Price: $35
Non-member Price: $50 -
Contains 4 Component(s), Includes Contact Hours
In this interactive session, expert genetic counselors will walk through challenging cases that highlight evolving genetic knowledge, nuanced risk assessment, and the counseling strategies needed to support patients facing difficult decisions.
Join us for an engaging, case-based webinar that brings the realities of genetic counseling into focus through complex, real-world clinical scenarios. In this interactive session, expert genetic counselors will present challenging cases, including a prenatal whole exome sequencing workup that led to variant reclassification, cascade testing across an extended family, and unexpected management implications for the pregnant patient; and a family undergoing repeated diagnostic and counseling shifts as new genetic evidence challenged established disease expectations. Together, these cases highlight evolving genetic knowledge, complex result interpretation, nuanced risk assessment, and the counseling strategies needed to support patients and families facing uncertainty.
Presented by:
1. Nour Chanouha, MS, CGC
2. Hannah S. Anderson, MS, CGCLearning Objectives:
1. Evaluate complex genetic results disclosure plans based on multiple clinical and psychosocial factors.
2. Describe how family history, fetal phenotype, and evolving variant interpretation can guide the interpretation of prenatal genetic testing and inform recurrence risk and family management.Genetic Counselor CEUs:
The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, Case Based Webinar - Part IV. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.
Successful Completion:
1. View recording
2. Pass quiz
3. Complete evaluationContent expires December 31, 2027.
Member Price: $35
Non-member Price: $50 -
Contains 4 Component(s), Includes Contact Hours
This webinar will review current approaches to the prenatal evaluation of suspected skeletal dysplasias and explore the challenges of prognostication in the context of uncertain or evolving information.
Prenatal skeletal dysplasias are among the most challenging conditions to diagnose and counsel prenatally due to variable phenotypic expression, evolving genotype-phenotype correlations, and limitations of prenatal imaging and molecular testing. While advances in genomic technologies have improved diagnostic capabilities, predicting clinical outcomes, including survival, severity, and long-term prognosis, often remains uncertain.
This webinar will review current approaches to the prenatal evaluation of suspected skeletal dysplasias and explore the challenges of prognostication in the context of uncertain or evolving information. Through clinical cases, participants will examine practical counseling strategies for communicating uncertainty, supporting informed decision-making, and providing patient-centered care for families navigating complex prenatal diagnoses of skeletal dysplasia.
Presented by:
NSGC Skeletal Dysplasia SIG
1. Shannon Persick, MS, CGCLearning Objectives:
1. Review the most common prenatal presentations of skeletal dysplasias.
2. Describe the major factors that contribute to prognostic uncertainty in prenatal skeletal dysplasia evaluation, including limitations of ultrasound examination, molecular testing, and genotype phenotype correlations.
3. Illustrate the spectrum of clinical outcomes associated with prenatal skeletal dysplasia diagnoses through real-life case examples.
4. Recognize common psychosocial challenges experienced by families navigating a new diagnosis of skeletal dysplasia in both the prenatal and neonatal periods.Genetic Counselor CEUs:
The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, Prenatal Skeletal Dysplasias: Navigating Prognostic Uncertainty and Counseling Challenges. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.
Successful Completion:
1. View recording
2. Pass quiz
3. Complete evaluationContent expires December 31, 2027.
Member Price: $35
Non-member Price: $50 -
Contains 4 Component(s), Includes Contact Hours
In this webinar, we discuss some common carrier screening findings for ocular and auditory conditions and offer strategies for providing a nuanced approach to genetic counseling about ocular and auditory conditions.
Advancements in genomic knowledge and next generation sequencing technologies have resulted in expanded carrier screening creating more equitable opportunities for individuals to learn about their reproductive risks for various genetic conditions including inherited eye and hearing conditions. For many of the ocular and auditory conditions included in carrier screening panels there are wide spectrums of phenotypic features including age of onset and severity. In this webinar, we discuss some common carrier screening findings for ocular and auditory conditions and offer strategies for providing a nuanced approach to genetic counseling about ocular and auditory conditions.
Presented by:
NSGC Ophthalmology and Hearing Loss SIG
1. Shay Guetz-Lindahl, MS, CGC
2. Emily Place, MS, LCGCLearning Objectives:
1. Define the spectrum of presentation of ocular genetic conditions found on carrier screening.
2. Define the spectrum of presentation of hearing loss genetic conditions on carrier screening.Genetic Counselor CEUs:
The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, Spectrum of Senses: Insights and Caveats for navigating ocular and auditory genetics in prenatal and preconception counseling. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.
Successful Completion:
1. View recording
2. Pass quiz
3. Complete evaluationContent expires December 31, 2027.
Member Price: $35
Non-member Price: $50 -
Contains 4 Component(s), Includes Contact Hours
This webinar examines how genetic counselors are implementing pharmacogenomics (PGx) testing and counseling across healthcare settings.
This webinar examines how genetic counselors are implementing pharmacogenomics (PGx) testing and counseling across healthcare settings. Over 95% of the population carries clinically significant pharmacogene variants, yet implementation lags behind other genetic testing due to limited workforce training, provider literacy gaps, and high clinical decision support costs. The presenters showcased three primary PGx service delivery models: academic medicine programs (Brigham & Women's Hospital telemedicine clinic and M Health Fairview's Go4PGx Initiative), private practice collaborations between genetic counselors and pharmacists, and laboratory-based models such as Color Health's integration with cancer clinics and research partnerships. Future challenges include managing increasingly complex sequencing-based and polygenic score PGx results while capitalizing on opportunities from long-read genomics and rapid sequencing technologies. Training programs and continuing education must expand to meet growing clinical integration of PGx and establish counselor competency as a hiring differentiator.
Presented by:
NSGC Precision Medicine SIG
1. Hannah Llorin, MS, CGC
2. Elizabeth Fieg, MS, CGC
3. Hetanshi Naik, PhD, MS, CGC
4. Jen Eichmeyer, MS, CGC
5. Jeri Nichols, MS, PharmD, CGC, CSP
6. Carla McGruder, MS, CGC
7. Rissa Hall, MS, CGCLearning Objectives:
1. Explain the clinical relevance and utility of pharmacogenomics (PGx)
2. Identify barriers to PGx implementation in genetic counseling practice and recognize emerging opportunities to advance the field
3. Compare genetic counselor roles and responsibilities across academic, private practice, and laboratory-based PGx modelsGenetic Counselor CEUs:
The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, From Niche to Necessary: Genetic Counselor-Led Pharmacogenomics Across the Care Continuum. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.
Successful Completion:
1. View recording
2. Pass quiz
3. Complete evaluationContent expires December 31, 2027.
Member Price: $35
Nonmember Price: $50 -
Contains 4 Component(s), Includes Contact Hours
This webinar will present recently published evidence-based, consensus driven practice recommendations for genetic testing of ataxias, focusing on an approach to clinical decision making, genetic counseling, and genetic testing.
This webinar will present recently published evidence-based, consensus driven practice recommendations for genetic testing of ataxias, focusing on an approach to clinical decision making, genetic counseling, and genetic testing. The presenters will highlight key updates from the publication, address common challenges, and discuss laboratory methodologies.
Presented by:
NSGC Neurology SIG
Amy Mook, MS, MPH, CGC
Michelle Rochman, MS, CGCLearning Objectives:
1. Describe the rationale for creating standardized genetic testing recommendations
2. Review the process for developing evidence-based, consensus driven guidelines
3. Recommend an approach for evaluation and counseling for patients with a personal and/or family history ataxia
4. Discuss considerations for test selection and associated methodologiesGenetic Counselor CEUs:
The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .01 CEUs or 1 Category 1 contact hour for the activity, Practice Recommendations for Genetic Testing of Ataxias. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.
Successful Completion:
1. View recording
2. Pass quiz
3. Complete evaluationContent expires December 31, 2027.
Member Price: $35
Non-member Price: $50 -
Contains 4 Component(s), Includes Contact Hours
Join the genetic counseling champions behind the NSGC Cancer Business Case Toolkit for an in-depth discussion of its development, strategic framework, and practical applications. This session will explore how the toolkit was created, how it can be effectively leveraged within your institution, and how its principles can inform the development of a compelling business case to integrate a genetic counselor into your practice.
Join the genetic counseling champions behind the NSGC Cancer Business Case Toolkit for an in-depth discussion of its development, strategic framework, and practical applications. This session will explore how the toolkit was created, how it can be effectively leveraged within your institution, and how its principles can inform the development of a compelling business case to integrate a genetic counselor into your practice.
Presented by:
Allison Harvey, MPH, CHES
Sara Pirzadeh-Miller, MS, CGC
Jaime Grund, MS, LGC
Stephanie Cohen, MS, LCGC
Charlie King, MGC, CGC
Kristen Shannon, MS, LCGC
Scott M. Weissman, MS, CGCLearning Objectives:
1. Describe the core elements of the NSGC Business Case Toolkit for oncology genetic counseling services.
2. Describe how toolkit elements can be applied to your practice
3. Recognize the importance of clinical, financial, and operational metrics in developing a sustainable oncology genetics programGenetic Counselor CEUs:
The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to 0.1 CEUs or 1 Category 1 contact hour for the activity, Making the Case: A Business Toolkit for Expanding Genetic Counseling in Oncology. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.
Successful Completion:
1. View recording
2. Pass quiz
3. Complete evaluationContent expires December 31, 2027.
Member Price: $35
Non-member Price: $50